PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
28-May-2021 Key updates ahead of SMi’s 4th Annual Pharmaceutical Microbiology West Coast Virtual Conference in three weeks! SMi Group
28-May-2021 Aptamer Group collaborates with world-leading pharmaceutical company to evaluate Optimer technology Aptamer Group
28-May-2021 Faster and more secure access to the gematik e-prescription with eHealth-Tec: Compatible software development kit for software providers Zur Rose Group AG
28-May-2021 Tagrisso approved in the EU for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer AstraZeneca
28-May-2021 MEDICLIN focuses on patient safety and innovative concepts in rehabilitation MediClin AG
28-May-2021 @ € edfbcnk' qqqqq
28-May-2021 Q1/21: Successful start to the year with sales growth (+9%) and significant earnings improvement (+91%) despite still burdening COVID-19 pandemic - restructuring successes clearly visible aap Implantate AG
28-May-2021 BRAIN Biotech AG H1 '20/'21 Results BRAIN Biotech AG
28-May-2021 Relief Appoints Dr. Taneli Jouhikainen as Chief Operating Officer RELIEF THERAPEUTICS Holdings AG
27-May-2021 Regensburg Center for Interventional Immunology adopts LUMICKS’ z-Movi® Cell Avidity Analyzer LUMICKS
27-May-2021 ONK Therapeutics Secures Exclusive Global License to Patent for CISH Knockout in NK Cells for the Treatment of Cancer, from Australia’s WEHI ONK Therapeutics
27-May-2021 FourPlus and Cell and Gene Therapy Catapult deliver cutting-edge VR training technology Cell and Gene Therapy Catapult (CGT Catapult) and FourPlus
27-May-2021 MIMETAS Opens Phenotypic Screening Center MIMETAS
27-May-2021 Novo Holdings Leads US$200M Series A investment in Asia-Based Life Sciences Tools Company Esco Lifesciences Group Novo Holdings
27-May-2021 Albireo Receives Positive CHMP Opinion for Bylvay™ (odevixibat) for Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) Albireo Pharma, Inc.
27-May-2021 euroPLX 76 Noordwijk Pharma Partnering Digital Only RauCon GmbH & Co. KG
27-May-2021 Albireo erhält eine positive CHMP-Beurteilung für Odevixibat zur Behandlung der progressiven familiären intrahepatischen Cholestase (PFIC) Albireo Pharma, Inc.
27-May-2021 Zai Lab Selects ENPICOM’s IGX Platform to Leverage New NGS-powered Antibody Discovery Workflows ENPICOM
27-May-2021 Zai Lab Selects ENPICOM’s IGX Platform to Leverage New NGS-powered Antibody Discovery Workflows B3C newswire
27-May-2021 Long-Term ERLEADA® ▼ (apalutamide) Patient-Reported Outcomes Data in Metastatic Hormone-Sensitive Prostate Cancer Demonstrate Maintenance of Health-Related Quality of Life for Patients Janssen Pharmaceutical Companies of Johnson & Johnson